Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Perkins

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nuclear Medicine Communications|July 9, 2014
InterviewAlan Perkins
Cancer Biotherapy & Radiopharmaceuticals|September 7, 2007
Update: aptamers as novel radiopharmaceuticals: their applications and future prospects in diagnosis and therapySotiris Missailidis, Alan Perkins
Lancet (London, England)|April 21, 2012
Diagnostic imagingPeter Morris, Alan Perkins
BMJ (Clinical Research Ed.)|September 9, 2008
Global shortage of medical isotopes threatens nuclear medicine servicesAlan Perkins, Andrew Hilson, John Hall
Nuclear Medicine Communications|February 5, 2024
Safety, biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 99m Tc-maraciclatide in healthy volunteersTatjana Gibbons, Alan Perkins, Jon Barnett
Documenta Ophthalmologica. Advances in Ophthalmology|July 3, 2014
Comparison of cathode ray tube and liquid crystal display stimulators for use in multifocal VEPMarÿke Fox, Colin Barber, David Keating, et al.
The Oncologist|February 27, 2003
Baseline and early treatment factors are not clinically useful for predicting individual response to erythropoietin in anemic cancer patientsTimothy J Littlewood, Martin Zagari, Christopher Pallister, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2005
Partial D-amino acid substitution: Improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptideRegina Tugyi, Katalin Uray, Dóra Iván, et al.
Neurogastroenterology and Motility|September 9, 2022
Tolerability, gastric emptying patterns, and symptoms during the Nottingham Test Meal in 330 secondary care non-diabetic dyspeptic patientsPeter D Hay, Maura Corsetti, Emily Tucker, et al.
Bioconjugate Chemistry|June 23, 2007
Design and synthesis of mono- and multimeric targeted radiopharmaceuticals based on novel cyclen ligands coupled to anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancerK Eszter Borbas, Catia S M Ferreira, Alan Perkins, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nuclear Medicine Communications|July 9, 2014
InterviewAlan Perkins
Cancer Biotherapy & Radiopharmaceuticals|September 7, 2007
Update: aptamers as novel radiopharmaceuticals: their applications and future prospects in diagnosis and therapySotiris Missailidis, Alan Perkins
Lancet (London, England)|April 21, 2012
Diagnostic imagingPeter Morris, Alan Perkins
BMJ (Clinical Research Ed.)|September 9, 2008
Global shortage of medical isotopes threatens nuclear medicine servicesAlan Perkins, Andrew Hilson, John Hall
Nuclear Medicine Communications|February 5, 2024
Safety, biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 99m Tc-maraciclatide in healthy volunteersTatjana Gibbons, Alan Perkins, Jon Barnett
Documenta Ophthalmologica. Advances in Ophthalmology|July 3, 2014
Comparison of cathode ray tube and liquid crystal display stimulators for use in multifocal VEPMarÿke Fox, Colin Barber, David Keating, et al.
The Oncologist|February 27, 2003
Baseline and early treatment factors are not clinically useful for predicting individual response to erythropoietin in anemic cancer patientsTimothy J Littlewood, Martin Zagari, Christopher Pallister, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2005
Partial D-amino acid substitution: Improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptideRegina Tugyi, Katalin Uray, Dóra Iván, et al.
Neurogastroenterology and Motility|September 9, 2022
Tolerability, gastric emptying patterns, and symptoms during the Nottingham Test Meal in 330 secondary care non-diabetic dyspeptic patientsPeter D Hay, Maura Corsetti, Emily Tucker, et al.
Bioconjugate Chemistry|June 23, 2007
Design and synthesis of mono- and multimeric targeted radiopharmaceuticals based on novel cyclen ligands coupled to anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancerK Eszter Borbas, Catia S M Ferreira, Alan Perkins, et al.
Pageof 2